DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity

Rhea-AI Summary

DuPont (NYSE: DD) has expanded its healthcare manufacturing facility in Heredia, Costa Rica with a 16,000-square-foot addition, marking a significant enhancement to its global sterile operations. The expansion enables Costa Rica's first-ever production of sterile healthcare packaging using Tyvek® technology, including pouches, header bags, and lids, while also increasing capacity for medical tubing operations. The ISO 13485:2016 and ISO 9001:2015 certified facility operates 24/7 and serves customers across the Caribbean and Americas. The facility strengthens DuPont's healthcare portfolio, which includes extruded tubing, catheter assembly, medical balloons, skin contact devices, smart wearables, and various medical device manufacturing capabilities.

Positive

• First company in Costa Rica and Caribbean to produce sterile packaging for medical devices
• 16,000-square-foot expansion increases production capacity for medical tubing and sterile packaging
• Facility operates 24/7 and holds ISO 13485:2016 and ISO 9001:2015 certifications
• Strategic expansion strengthens DuPont's position as a supply chain partner for global healthcare companies

Negative

• None.

Insights

Manufacturing and Healthcare Supply Chain Expert

DuPont's Costa Rica expansion strengthens its healthcare portfolio with sterile packaging capabilities, enhancing regional manufacturing presence and supply chain resilience.

The 16,000-square-foot expansion of DuPont's Heredia facility represents a strategic enhancement of the company's healthcare manufacturing capabilities in the Americas. This development is significant for two key reasons: it marks Costa Rica's first-ever production of sterile healthcare packaging utilizing Tyvek® technology, and it increases capacity for the site's existing medical tubing operations.

The facility now operates on a 24/7 production schedule and has secured the critical ISO 13485:2016 and ISO 9001:2015 certifications, which are essential quality management standards for medical device manufacturing. This ensures DuPont can meet the stringent regulatory requirements of the healthcare industry while maintaining consistent product quality.

From a manufacturing perspective, this expansion enhances DuPont's regional production network, potentially reducing lead times and shipping costs for customers in the Americas. The geographic diversification of sterile packaging production also strengthens supply chain resilience – a critical factor for medical device manufacturers following recent global supply disruptions.

The facility's dual functionality – producing both medical tubing and sterile packaging – creates operational synergies that can improve manufacturing efficiency. By consolidating these complementary operations at a single site, DuPont can better coordinate production schedules, reduce logistics complexity, and potentially achieve economies of scale in their healthcare business segment.

The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging.

WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.

To serve Healthcare customers in the Caribbean and more broadly across the Americas, the Heredia operation has expanded by 16,000 square feet. The new space accommodates additional extrusion equipment and production lines, enabling production of sterile packaging leveraging Tyvek^® – such as pouches, header bags and lids – and increasing DuPont's extruded tubing production capacity.

The new expansion is ISO 13485:2016 and ISO 9001:2015 certified, with its technical, assembly and packaging staff adhering to the highest quality standards and protocols. To support current and new customers, the facility is operating on a 24/7 production schedule.

"With this expansion, we are now the first company in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry," said James Chambers, Senior Vice President and General Manager for Fluids & Flexibles at Spectrum Plastics Group, A DuPont Business. "This significantly enhances our robust, growing portfolio of unmatched offerings and capabilities as a trusted supply chain partner to leading global healthcare companies."

DuPont's products, services and expertise for the healthcare industry include extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining and sterile packaging enabled by Tyvek^®.

Combining medical-grade performance materials, component and device solutions, and innovative technology, DuPont offers full-service, comprehensive solutions that support a range of healthcare applications. Learn more about DuPont's healthcare solutions at healthcare.dupont.com.

About Spectrum Plastics Group, A DuPont Business
Acquired by DuPont in August 2023, Spectrum Plastics Group, A DuPont Business, brings over 60 years of expertise in advanced polymer processing and medical device manufacturing. The company specializes in precision extrusion, specialty injection molding, blown film extrusion and conversion, medical balloon fabrication, laser processing, additive manufacturing, and complex catheter and device assembly. Spectrum is recognized as a leading trusted supplier for the development and production manufacturing of critical polymer-based components and finished devices for the medical device market and other high-performance applications. With global facilities and more than 1 million square feet of manufacturing space, Spectrum delivers proven quality, innovation and technical excellence to solve the most demanding customer challenges. The company supports a broad range of healthcare applications across the biopharmaceutical processing, medical device and pharmaceutical markets. More information can be found at spectrumplastics.com.

About DuPont 
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ^SM or ^® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-expands-healthcare-manufacturing-site-in-costa-rica-adding-sterile-packaging-capacity-302473762.html

SOURCE DuPont

FAQ

What is the size of DuPont's (DD) new facility expansion in Costa Rica?

DuPont's facility expansion in Heredia, Costa Rica is 16,000 square feet.

What products will DuPont (DD) manufacture at its expanded Costa Rica facility?

The facility will produce sterile packaging using Tyvek® technology (pouches, header bags, and lids) and increase production of extruded medical tubing.

What certifications does DuPont's (DD) Costa Rica healthcare facility have?

The facility is certified with ISO 13485:2016 and ISO 9001:2015 standards.

How will the Costa Rica expansion impact DuPont's (DD) healthcare operations?

The expansion makes DuPont the first company in Costa Rica and Caribbean to produce sterile packaging for medical devices, while enhancing its global sterile operations and medical tubing production capacity.

What regions will DuPont's (DD) expanded Costa Rica facility serve?

The facility will serve healthcare customers in the Caribbean and across the Americas.